Scancell Holdings

www.scancell.co.uk

Department of Clinical Oncology
City Hospital Hucknall Road
Nottingham
NG5 1PB
United Kingdom

+44 115 823 1863

Activities

Research & Development | Pharmaceutical

Related Companies

Related Content

Cobra collaborates with Scancell on COVID-19 vaccine plasmids
Cobra collaborates with Scancell on COVID-19 vaccine plasmids
Scancell establishes clinical advisory board
Scancell establishes clinical advisory board
Scancell receives European patent for immunotherapy platform
Scancell receives European patent for immunotherapy platform
Scancell team shortlisted for Cancer Research UK’s Grand Challenge award
Scancell team shortlisted for Cancer Research UK’s Grand Challenge award
Collaboration to investigate T cell receptors for cancer treatment
Collaboration to investigate T cell receptors for cancer treatment
Scancell appoints Dr Cliff Holloway as CEO
Scancell appoints Dr Cliff Holloway as CEO
DNA ImmunoBody patent granted in Europe
DNA ImmunoBody patent granted in Europe
Scancell appoints Eurogentec to manufacture new SCIB1 material for cancer vaccine trial
Scancell appoints Eurogentec to manufacture new SCIB1 material for cancer vaccine trial
Scancell suspends dosing with SCIB1
Scancell suspends dosing with SCIB1
Key management changes aim to support future growth at Scancell
Key management changes aim to support future growth at Scancell
Scancell embarks on strategic collaboration with a world-leading research team at the Karolinska Institutet
Scancell embarks on strategic collaboration with a world-leading research team at the Karolinska Institutet
Sally Adams joins Scancell Holdings Board as Development Director
Sally Adams joins Scancell Holdings Board as Development Director
Scancell collaborates with ImmuneRegen BioSciences
Scancell collaborates with ImmuneRegen BioSciences
Nottingham scientists test cancer vaccine
Nottingham scientists test cancer vaccine